Has Santosh Oommen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,489 in general payments to Santosh Oommen, MD across 98 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Santosh Oommen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Santosh Oommen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Santosh Oommen, MD

Clinical Cardiac Electrophysiology · Monterey, CANPI 1427104256

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,604 of the $7,489 with a category attached, or 61.5%. 11 manufacturers reported payments, led by Abbott at 47.3% of the total. Reporting peaked in 2024 at $2,949 and has fallen 65.0% since, to $1,031 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CA, where the typical reported total is $26,911.

$7,489in general payments, 2019–2025

Across 98 payments — averaging $76.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Biosense Webster, Inc.$1K
Boston Scientific$731
Medical Device Business Services, Inc.$709
Medtronic$470
Elutia, Inc.$160
plus $503 from 5 others

What the payments were for

Travel & lodging$2,88539%
Food & beverage$4,60461%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	29	$3,543
Biosense Webster, Inc.	29	$1,373
Boston Scientific	17	$731
Medical Device Business Services, Inc.	2	$709
Medtronic	10	$470
Elutia, Inc.	1	$160
Philips North America LLC	2	$159
Biotronik Inc.	1	$124
Atricure, Inc.	3	$105
Chiesi USA, Inc.	2	$79
E.r. Squibb & Sons, L.L.C.	2	$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AVEIR$1,692
Carto 3 System$827
ENSITE$656
Carto 3$316
EnSite Precision Cardiac Mapping System$253
ENSITE PRECISION$196
Rhythmia Mapping System$171
SelectSecure$164
ECM Patch,Pouch$160
AMVIA EDGE$124
HeartMate 3 Left Ventricular Dev$104

How this compares

$7,489 in reported general payments places this provider in the 20th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024

$372,937

Medicare patients

1,037

Services billed

3,752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	324	$457,426
XareltoRivaroxaban	135	$186,860
EntrestoSacubitril/Valsartan	31	$37,369
FarxigaDapagliflozin Propanediol	20	$24,071
Dofetilide	45	$23,779
Flecainide Acetate	105	$6,343
Metoprolol Succinate	340	$6,139
Propafenone Hcl	31	$2,725
Diltiazem 24hr Er (Cd)Diltiazem Hcl	57	$2,386
Mexiletine Hcl	14	$1,595
Lisinopril	111	$1,588
Atorvastatin Calcium	93	$1,421
Carvedilol	109	$1,272
Bumetanide	20	$1,159
Spironolactone	92	$976

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Monterey

Shephal DoshiSanta Monica$2.1M
Jonathan HsuSan Diego$1.2M
Leslie SaxonLos Angeles$1.1M
Rahul BhardwajLoma Linda$935K
Nicholas Olsonla Jolla$801K
Jonathan DukesVentura$775K
Brett GidneySanta Barbara$756K
John Rogersla Jolla$738K
Rajesh BankerNewport Beach$538K
Rahul DoshiLos Angeles$469K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →